The Food and Drug Administration approved a multiple-sclerosis drug called Ocrevus, the first treatment for the most severe type of the disease, known as primary progressive MS.
read more
The Food and Drug Administration approved a multiple-sclerosis drug called Ocrevus, the first treatment for the most severe type of the disease, known as primary progressive MS.
read more